|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM258583703 |
003 |
DE-627 |
005 |
20231224185324.0 |
007 |
cr uuu---uuuuu |
008 |
231224s2016 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2016.03.009
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0861.xml
|
035 |
|
|
|a (DE-627)NLM258583703
|
035 |
|
|
|a (NLM)26993753
|
035 |
|
|
|a (PII)S1521-6616(16)30037-7
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Fan, Tingting
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Treating psoriasis by targeting its susceptibility gene Rel
|
264 |
|
1 |
|c 2016
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 31.08.2016
|
500 |
|
|
|a Date Revised 19.04.2016
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2016 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a Psoriasis is a chronic inflammatory disorder of the skin. Accumulating evidence indicates that the Rel gene, a member of the NF-κB family, is a risk factor for the disease. We sought to investigate whether psoriasis can be prevented by directly targeting the Rel gene transcript, i.e., the c-Rel mRNA. Using chemically-modified c-Rel specific siRNA (siRel) and poly(ethylene glycol)-b-poly(l-lysine)-b-poly(l-leucine) (PEG-PLL-PLLeu) micelles, we successfully knocked down the expression of c-Rel, and showed that the expression of cytokine IL-23, a direct target of c-Rel that can drive the development of IL-17-producing T cells, was markedly inhibited. More importantly, treating mice with siRel not only prevented but also ameliorated imiquimod (IMQ)-induced psoriasis. Mechanistic studies showed that siRel treatment down-regulated the expression of multiple inflammatory cytokines. Taken together, these results indicate that the susceptibility gene Rel can be targeted to treat and prevent psoriasis
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a IL-17A
|
650 |
|
4 |
|a PEG-PLL-PLLeu micelles
|
650 |
|
4 |
|a Psoriasis
|
650 |
|
4 |
|a c-Rel
|
650 |
|
4 |
|a siRNA
|
650 |
|
7 |
|a RNA, Small Interfering
|2 NLM
|
650 |
|
7 |
|a RNA-Induced Silencing Complex
|2 NLM
|
700 |
1 |
|
|a Wang, Shaowen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yu, Linjiang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yi, Huqiang
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Liu, Ruiling
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Geng, Wenwen
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Wan, Xiaochun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ma, Yifan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cai, Lintao
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Chen, Youhai H
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ruan, Qingguo
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 165(2016) vom: 15. Apr., Seite 47-54
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:165
|g year:2016
|g day:15
|g month:04
|g pages:47-54
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2016.03.009
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 165
|j 2016
|b 15
|c 04
|h 47-54
|